National Biotechnology Centre (CNB-CSIC)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Co-director of the Microbiome Analysis Laboratory and Research Professor
Co-director of the coronavirus group at the National Biotechnology Centre (CNB-CSIC)
Research professor at the National Biotechnology Centre (CNB-CSIC) and at the CIBERER-ISCIII
CNB-CSIC Scientific Researcher at the CiMUS of the University of Santiago de Compostela, IDIS. Laboratory of Cell Senescence, Cancer and Aging
Virologist at the National Center for Biotechnology (CNB-CSIC)
Researcher at the National Biotechnology Centre (CNB-CSIC)
Researcher specialized in ecology and evolution of antibiotic resistance.
Virologist at the National Biotechnology Centre (CNB-CSIC)
CSIC Research Professor at the National Center of Biotechnology
A team of researchers from the Health Institute Carlos III has published an article quantifying the diagnostic delay of rare diseases in Spain with data from the period 1960-2021. The study reveals that more than half of the patients experienced a delay in diagnosis, that the average delay exceeds six years, and that both the percentage of those affected by the delay and the average time have decreased over the years.
The Spanish Confederation of Scientific Societies (COSCE) has just published a report, submitted to the EU, which proposes and compares different possibilities for reform of the regulatory framework for genome editing techniques.
During Pfizer's appearance before the European Parliament this week, a company executive responded to the question of whether "Pfizer's vaccine was tested to stop transmission of the virus (SARS-CoV-2) before going to market" by saying "no".
A US team has successfully integrated brain-like tissue derived from human stem cells into the brains of newborn rats. The research is published in the journal Nature.
To estimate the effectiveness of two or three doses of vaccines against covid-19 infection and hospitalisation, researchers in Denmark conducted a study of all previously uninfected Danish residents aged 12 years and older. The conclusion of the research, which is published in PLOS Medicine, is that a third dose provided greater protection against infection and hospitalisation with omicron than two vaccines.
The extraordinary plenary session of the Congress of Deputies today approved the reform of the Law on Science, Technology and Innovation. After being passed in the Lower House without any votes against it on 23 June, the bill was approved in the Senate on 20 July with an amendment referring to indefinite-term contracts, which was rejected today in Congress.
Research published in Nature shows the creation of synthetic mouse embryos derived from stem cells. The embryo model copies the stages of natural rodent embryo development that take place up to day 8.5 after fertilisation and includes regions of the brain, a neural tube and a structure similar to a beating heart.
The variety of current dog breeds is the product of two centuries of human intervention, which has often selected characters for extravagance or supposed aesthetics. Lluís Montoliu, president of the CSIC Ethics Committee until last February, recalls that 15% of current dog breeds have some sort of more or less serious congenital disease.
The Minister of Health, Carolina Darias, announced in an interview on La Sexta that there will be a fourth dose of the covid-19 vaccine "for the entire population".
In a press release published this week, Moderna has shared the first data on its new bivalent adapted vaccine against Omicron.